ELV

SELL

Elevance Health, Inc.

Healthcare · Rank #428 · Analyzed Jul 13, 2026

$416.23

Current Price

$394.75

Intrinsic Value

-5.2%

Upside/Downside

1/10

Score

1/5

Quality

Analysis Summary

Valuation Consensus0/2 methods agree

Quality Score1/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 5.2%

Fair Value Range

Low$314.96

Base (IV)$394.75

High$478.35

Entry Points

Conservative$220.47

Moderate$314.96

Aggressive$276.33

Quality & Moat Breakdown

Return on Equity12.1% → 0.5/1.0

Debt LevelD/E 72 → 0/1.0

Revenue QualityGrowth 12.6%, margin Δ+0.0% → 0.5/1.0

Moat Strength0.5/5 → 0/1.0

Profit Margins2.6% → 0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.